Table 3.
Correlations between final and baseline anthropometric and metabolic parameters.
| Parameters at the Baseline Examination | Parameters at the Follow-Up | ||
|---|---|---|---|
| BMI (kg/m2) | Waist Circumference (cm) | Body Fat (%) | |
| BMI (kg/m2) | 0.94 *** | 0.88 *** | 0.85 *** |
| Waist Circumference (cm) | 0.88 *** | 0.88 *** | 0.82 *** |
| Fat Mass (%) | 0.89 *** | 0.85 *** | 0.87 *** |
| Glucose 0’ (mg/dL) | 0.35 p = 0.05 | 0.32 p = 0.08 | 0.40 * |
| Mean Glucose (mg/dL) | 0.42 * | 0.45 * | 0.51 ** |
| Insulin 0’ (uIU/mL) | 0.51 ** | 0.51 ** | 0.60 *** |
| Mean Insulin (uIU/mL) | 0.61 *** | 0.58 *** | 0.72 *** |
| M-Clamp Value (mg/kgffm/min) | −0.68 *** | −0.65 *** | −0.70 *** |
| Matsuda Index | −0.62 *** | −0.61 *** | −0.75 *** |
| HOMA-IR Score | 0.59 *** | 0.59 *** | 0.66 *** |
| Triglycerides (mg/dL) | 0.55 ** | 0.46 ** | 0.56 *** |
| HDL-c (mg/dL) | −0.55 ** | −0.49 ** | −0.53 ** |
| SHBG (nmol/l) | −0.52 ** | −0.43 * | −0.56 ** |
Data are shown as r correlation coefficient. Significance levels are indicated by asterisks (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Correlation coefficients were estimated by Spearman’s correlation for all parameters. BMI, body mass index; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; M-clamp value, insulin sensitivity estimated with the euglycaemic hyperinsulinaemic clamp technique; SHBG, sex hormone-binding globulin.